Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-150-1 | CAS number: 61791-00-2 1 - 2.5 moles ethoxylated
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test substance was not irritant or corrosive to the skin in a GLP-compliant OECD 431 and 439 study.
The test substance was not irritant to the eyes in a GLP-compliant OECD 492 study.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
SKIN IRRITATION
By using the currently available methods a single in vitro assay is not sufficient to cover the full range of skin irritating/corrosion potential. Therefore, two in vitro assays were part of an in vitro skin irritation and corrosion test strategy (BASF 2017): The Skin Corrosion Test (SCT) and Skin Irritation Test (SIT). However, the results derived with SIT (performed in a GLP-compliant study according to OECD 431, OECD 439, EU method B.40 BIS. And EU method B.46) alone were sufficient for a final assessment. Therefore, further testing in SCT was waived.
The potential of the test substance to cause dermal irritation was assessed by a single topical application of 30 µL of the undiluted test substance to a reconstructed three-dimensional human epidermis model (EpiDerm™). The irritation test was performed with three EpiDerm™ tissues which were incubated with the test substance for 1 hour followed by a 42-hour post-incubation period.
Tissue destruction was determined by measuring the metabolic activity of the tissue after exposure/post-incubation by using a colorimetric test. The reduction of mitochondrial dehydrogenase activity measured by reduced formazan production after incubation with a tetrazolium salt (MTT) was chosen as endpoint. The formazan production of the epidermal tissues treated with the test substance is compared to that of negative control tissues. The quotient of the values indicates the relative tissue viability.
The following results were obtained in the EpiDerm™ skin irritation test: 1) The test substance is able to directly reduce MTT. Therefore, an additional MTT reduction control KC (freeze-killed control tissues) was introduced. 2) The final mean viability of the tissues treated with the test substance determined after an exposure period of 1 hour with an about 42-hour post-incubation was 100.7%.
Based on the results observed and by applying the evaluation criteria, it was concluded that the test substance does not show a skin irritation potential in the EpiDerm™ in vitro skin irritation and corrosion test strategy under the test conditions chosen.
In a supporting skin irritation test two rabbits were treated for 1, 5, 15 min and 20 hours under occlusive conditions (BASF 1971). An application site of 2.5 x 2.5 cm was covered with the liquid test substance. After the application time (1, 5, 15 min and 20 h) the skin was washed with Lutrol (50%). The animals were observed for 8 days and skin changes were recorded daily. The report describes findings after 24 hours and at the end of the observation period (8 days). After 20 hours exposure to the test-substance one animals showed slight erythema after 24 hours (score 2). The observed redness was resolved by the end of the observation period, but a slight scaling was still present. The other animal exposed for 20 hours showed only some questionable erythema effect after 24 hours (score 1) which was fully reversible within 72 hours. No other effects were noted in the animals exposed for 20 hours. Of the animals exposed for shorter periods (1, 5, or 15 minutes) only one animal exposed for 15 minutes showed some questionable erythema which was fully reversible.
In another similar performed skin irritation test showed stronger effects (BASF 1966). The animals exposed for 20 hours showed strong to very strong erythema across the whole exposed area. After 8 days the redness in one animal was decreased to slight and had disappeared in the other. However, strong scaling was observed in both animals. In addition to the erythema a slight swelling was seen at 24 hours which also had disappeared after 8 days. The animals exposed for 15 minutes showed questionable erythema which was fully reversible. No ulcers, bleeding, or bloody scabs were observed. Animals exposed for shorter period did not show any signs of irritation. The OECD guideline 404 (Acute Dermal Irritation/Corrosion) states a typical exposure duration of 4 hour under open or semi-occlusive conditions. Therefore the test employing 20 hours exposure under occlusive conditions is considered a worst case situation,
Severe skin irritating effects were only seen in one of the study, however considering the worst case conditions these effects are questionable. In contrast, the in vitro guideline study the test substance was considered not to be skin irritant, which is supported by the other in vivo study.
EYE IRRITATION
The eye irritating potential of the test substance was tested in vitro (BASF 2017). By using the methods currently available a single in vitro assay is not sufficient to cover the full range of eye irritating potential. Therefore, two in vitro assays were part of this in vitro eye irritation test strategy: The Bovine Corneal Opacity and Permeability Test (BCOP Test) and EpiOcular Eye Irritation Test. However, in the current case the results derived with the EpiOcular test alone (which was applied conforming GLP and in accordance with OECD 492) were sufficient for a final assessment. Therefore, further testing in BCOP was waived.
The potential of the test substance to cause ocular irritation was assessed by a single topical application of 50 µL undiluted test substance to a reconstructed three-dimensional, human cornea model (EpiOcular™). Two EpiOcular™ tissues were incubated with the test substance for 30 minutes followed by a 2-hour post-incubation period. Tissue destruction was determined by measuring the metabolic activity of the tissue after exposure/post-incubation by using a colorimetric test. The reduction of mitochondrial dehydrogenase activity measured by reduced formazan production after incubation with a tetrazolium salt (MTT) was chosen as endpoint. The formazan production of the epidermal tissues treated with the test substance is compared to that of negative control tissues. The ratio of the values indicates the relative tissue viability. The following results were obtained in the EpiOcular™ eye irritation assay: 1) The test substance is able to directly reduce MTT. Therefore, an additional MTT reduction control (freeze-killed control tissues (KC)) was introduced. 2) The final mean viability of the tissues treated with the test substance was 109.3%.
Based on the results observed in the EpiOcular Test alone and by applying the evaluation criteria, it was concluded that the test substance does not show an eye irritation potential in the in vitro eye irritation test strategy under the test conditions chosen.
In a supporting eye irritation test (BASF 1971) 50 µL of the test substance were applied to the conjunctival sac of one eye in 2 animals. The adjacent eye served as saline-control. The animals were observed after 1 and 24 h on the day of treatment and up to 8 days afterwards. The eyes were not washed out after 24 hours as specified in OECD Guideline 405. One hour after application of the test substance slight redness of the conjunctivae was observed in both animals. After 24 hours one animals still showed slight redness of the conjunctivae while the effects in the other animal were completely reversed. After 8 days both animals were without eye irritating effects.
In another supporting eye irritation test (BASF 1966) of the same design and exposure regime similar results were obtained. One hour after application of the test substance slight redness of the conjunctivae was observed in both animals. After 24 hours no eye irritation effect were observed until the end of the observation period. Based on these results, the test substance is considered to be not irritating to the eyes.
Justification for classification or non-classification
Based on the available information, classification for skin and eye irritation is not warranted, in accordance with EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation No. (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.